GlassScriptPhysician profile
Aaron N Rockoff
NPI 1902104839
$13,714.96
in general payments reported to CMS, 2019-2025
53 companies · $2,573 in 2025
The $2,573 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,771 · 2020: $1,349 · 2021: $1,845 · 2022: $1,878 · 2023: $1,813 · 2024: $2,486 · 2025: $2,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,848 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,847.52 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $2,431.60 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Amgen INC. | $1,620.52 | 2019-2025 | Tepezza, Evenity, Repatha |
| Novo Nordisk INC | $1,239.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $584.00 | 2019-2025 | Omnipod |
| Abbvie INC. | $548.52 | 2019-2025 | Synthroid |
| Astrazeneca Pharmaceuticals LP | $471.41 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $459.81 | 2019-2025 | |
| Mannkind Corporation | $455.81 | 2020-2024 | Afrezza |
| Novartis Pharmaceuticals Corporation | $440.47 | 2022-2025 | |
| Corcept Therapeutics | $396.98 | 2019-2025 | Korlym |
| Abbott Laboratories | $384.21 | 2019-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.03 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $295.99 | 2021-2025 | |
| Dexcom, INC. | $294.38 | 2020-2025 | Dexcom G6 Transmitter |
| Bigfoot Biomedical INC | $286.47 | 2021-2022 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $285.15 | 2020-2025 | Tymlos |
| Tandem Diabetes Care, INC. | $221.80 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Antares Pharma, INC. | $220.48 | 2019-2024 | Xyosted |
| Recordati_rare_diseases_inc. | $186.65 | 2024-2025 | Isturisa, Signifor Lar |
| Cequr Corporation | $179.24 | 2022-2025 | Cequr Simplicity |
| Ascendis Pharma Endocrinology INC | $159.33 | 2024-2025 | Yorvipath |
| Madrigal Pharmaceuticals | $152.57 | 2024-2025 | Rezdiffra, Resmetirom |
| Horizon Therapeutics Plc | $144.69 | 2019-2023 | Tepezza |
| Medtronic, INC. | $143.46 | 2021-2025 | Minimed 780g |
| Becton, Dickinson and Company | $132.86 | 2022 | |
| Alexion Pharmaceuticals, INC. | $113.21 | 2023-2024 | Strensiq |
| Xeris Pharmaceuticals, INC. | $104.48 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $104.25 | 2019-2023 | Steglatro |
| Ibsa Pharma INC. | $99.04 | 2019-2025 | Tirosint, Licart, Flector |
| Beta Bionics, INC. | $86.01 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Theratechnologies INC. | $85.00 | 2022 | |
| Currax Pharmaceuticals LLC | $79.93 | 2022-2025 | Contrave, Nexletol |
| Kyowa Kirin, INC. | $78.65 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $77.32 | 2024-2025 | |
| Medtronic Minimed, INC. | $74.19 | 2019-2020 | |
| Pfizer INC. | $73.40 | 2021-2023 | |
| Tolmar, INC. | $72.87 | 2024-2025 | Jatenzo |
| Ipsen Biopharmaceuticals, INC | $67.42 | 2019-2021 | |
| Embecta Corp. | $66.07 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Sequel Med Tech, LLC | $63.07 | 2025 | Twiist |
| Janssen Pharmaceuticals, INC | $57.18 | 2019-2020 | |
| Alvogen INC | $56.41 | 2023-2024 | Teriparatide |
| Amphastar Pharmaceuticals, INC. | $45.77 | 2024-2025 | |
| Zealand Pharma US, INC. | $45.43 | 2021 | |
| Ascensia Diabetes Care US INC. | $36.41 | 2023 | |
| Amarin Pharma, INC. | $30.69 | 2020 | |
| Rhythm Pharmaceuticals, INC. | $27.84 | 2025 | Imcivree |
| Sun Pharmaceutical Industries INC. | $25.56 | 2020 | |
| Eisai INC. | $24.21 | 2024 | |
| Boston Scientific Corporation | $22.14 | 2025 | General - Pain Management |
| Amneal Pharmaceuticals LLC | $15.13 | 2019 | |
| Valeritas, INC. | $14.46 | 2019 | |
| Alfasigma USA, INC. | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Rockoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.